292
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Development and Validation of a Risk Nomogram Model for Predicting Constipation in Patients with Type 2 Diabetes Mellitus

, , , ORCID Icon, , , ORCID Icon & show all
Pages 1109-1120 | Received 02 Feb 2023, Accepted 12 Apr 2023, Published online: 20 Apr 2023

References

  • Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414(6865):782–787. doi:10.1038/414782a
  • Mayer-Davis EJ, Lawrence JM, Dabelea D, et al. Incidence trends of type 1 and type 2 diabetes among youths, 2002-2012. N Engl J Med. 2017;376(15):1419–1429. doi:10.1056/NEJMoa1610187
  • Divers J, Mayer-Davis EJ, Lawrence JM, et al. Trends in incidence of type 1 and type 2 diabetes among youths - selected counties and Indian reservations, United States, 2002-2015. Mmwr Morb Mortal Wkly Rep. 2020;69(6):161–165. doi:10.15585/mmwr.mm6906a3
  • Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet. 2017;389(10085):2239–2251. doi:10.1016/S0140-6736(17)30058-2
  • Tomic D, Shaw JE, Magliano DJ. The burden and risks of emerging complications of diabetes mellitus. Nat Rev Endocrinol. 2022;18(9):525–539. doi:10.1038/s41574-022-00690-7
  • Du YT, Rayner CK, Jones KL, et al. Gastrointestinal symptoms in diabetes: prevalence, assessment, pathogenesis, and management. Diabetes Care. 2018;41(3):627–637. doi:10.2337/dc17-1536
  • Sommers T, Mitsuhashi S, Singh P, et al. Prevalence of chronic constipation and chronic diarrhea in diabetic individuals in the United States. Am J Gastroenterol. 2019;114(1):135–142. doi:10.1038/s41395-018-0418-8
  • Sangnes DA, Lundervold K, Bekkelund M, et al. Gastrointestinal transit and contractility in diabetic constipation: a wireless motility capsule study on diabetes patients and healthy controls. United European Gastroenterol J. 2021;9(10):1168–1177. doi:10.1002/ueg2.12169
  • Sumida K, Molnar MZ, Potukuchi PK, et al. Constipation and risk of death and cardiovascular events. Atherosclerosis. 2019;281:114–120. doi:10.1016/j.atherosclerosis.2018.12.021
  • Prasad VG, Abraham P. Management of chronic constipation in patients with diabetes mellitus. Indian J Gastroenterol. 2017;36(1):11–22. doi:10.1007/s12664-016-0724-2
  • Yoshinobu S, Hasuzawa N, Nagayama A, et al. Effects of elobixibat, an inhibitor of ileal bile acid transporter, on glucose and lipid metabolism: a single-arm pilot study in patients with t2dm. Clin Ther. 2022. doi:10.1016/j.clinthera.2022.08.009
  • Bandini M, Fossati N, Briganti A. Nomograms in urologic oncology, advantages and disadvantages. Curr Opin Urol. 2019;29(1):42–51. doi:10.1097/MOU.0000000000000541
  • Balachandran VP, Gonen M, Smith JJ, et al. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16(4):e173–e180. doi:10.1016/S1470-2045(14)71116-7
  • Morlacco A, Modonutti D, Motterle G, et al. Nomograms in urologic oncology: lights and shadows. J Clin Med. 2021;10:5. doi:10.3390/jcm10050980
  • Summers RM. Nomograms for automated body composition analysis: a crucial step for routine clinical implementation. Radiology. 2021;298(2):330–331. doi:10.1148/radiol.2020203956
  • Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a who consultation. Diabet Med. 1998;15(7):539–553. doi:10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
  • Qaseem A, Vijan S, Snow V, et al. Glycemic control and type 2 diabetes mellitus: the optimal hemoglobin a1c targets. A guidance statement from the American college of physicians. Ann Intern Med. 2007;147(6):417–422. doi:10.7326/0003-4819-147-6-200709180-00012
  • Ding L, Xu Y, Liu S, et al. Hemoglobin a1c and diagnosis of diabetes. J Diabetes. 2018;10(5):365–372. doi:10.1111/1753-0407.12640
  • Baykan H, Baykan O, Durmaz O, et al. Plasma neuropeptide-s levels in populations diagnosed with generalized anxiety disorder: a controlled study. Noro Psikiyatr Ars. 2019;56(1):52–56. doi:10.29399/npa.22907
  • Tack J, Talley NJ. Functional dyspepsia--symptoms, definitions and validity of the Rome iii criteria. Nat Rev Gastroenterol Hepatol. 2013;10(3):134–141. doi:10.1038/nrgastro.2013.14
  • Sauerbrei W, Boulesteix AL, Binder H. Stability investigations of multivariable regression models derived from low- and high-dimensional data. J Biopharm Stat. 2011;21(6):1206–1231. doi:10.1080/10543406.2011.629890
  • Rodrigues ML, Motta ME. Mechanisms and factors associated with gastrointestinal symptoms in patients with diabetes mellitus. J Pediatr (Rio J). 2012;88(1):17–24. doi:10.2223/JPED.2153
  • Ghadiri-Anari A, Gholami S, Zolfaghari F, et al. Prediabetes and gastrointestinal (gi) symptoms; A cross-sectional study. Diabetes Metab Syndr. 2019;13(1):844–846. doi:10.1016/j.dsx.2018.12.005
  • Bytzer P, Talley NJ, Leemon M, et al. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med. 2001;161(16):1989–1996. doi:10.1001/archinte.161.16.1989
  • Chandrasekharan B, Anitha M, Blatt R, et al. Colonic motor dysfunction in human diabetes is associated with enteric neuronal loss and increased oxidative stress. Neurogastroenterol Motil. 2011;23(2):131–138, e26. doi:10.1111/j.1365-2982.2010.01611.x
  • Thaiss CA, Levy M, Grosheva I, et al. Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection. Science. 2018;359(6382):1376–1383. doi:10.1126/science.aar3318
  • Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54(6):1615–1625. doi:10.2337/diabetes.54.6.1615
  • Yamada E, Namiki Y, Takano Y, et al. Clinical factors associated with the symptoms of constipation in patients with diabetes mellitus: a multicenter study. J Gastroenterol Hepatol. 2018;33(4):863–868. doi:10.1111/jgh.14022
  • Black CJ, Ford AC. Chronic idiopathic constipation in adults: epidemiology, pathophysiology, diagnosis and clinical management. Med J Aust. 2018;209(2):86–91. doi:10.5694/mja18.00241
  • Lucak S, Lunsford TN, Harris LA. Evaluation and treatment of constipation in the geriatric population. Clin Geriatr Med. 2021;37(1):85–102. doi:10.1016/j.cger.2020.08.007
  • Cui S, Yang Q, Xie S, et al. Acupuncture for chronic constipation in patients with diabetes mellitus: a protocol for systematic review. Medicine. 2021;100(9):e24886. doi:10.1097/MD.0000000000024886
  • Kirwan JP, Sacks J, Nieuwoudt S. The essential role of exercise in the management of type 2 diabetes. Cleve Clin J Med. 2017;84(7Suppl 1):S15–S21. doi:10.3949/ccjm.84.s1.03
  • Warner SO, Yao MV, Cason RL, et al. Exercise-induced improvements to whole body glucose metabolism in type 2 diabetes: the essential role of the liver. Front Endocrinol (Lausanne). 2020;11:567. doi:10.3389/fendo.2020.00567
  • Gao R, Tao Y, Zhou C, et al. Exercise therapy in patients with constipation: a systematic review and meta-analysis of randomized controlled trials. Scand J Gastroenterol. 2019;54(2):169–177. doi:10.1080/00365521.2019.1568544
  • Tariq O, Rosten C, Huber J. Experiences of living with type 2 diabetes in Pakistan: the role of culture and family in physical activity. Int J Equity Health. 2022;21(1):103. doi:10.1186/s12939-022-01706-4
  • Schacter GI, Leslie WD. Diabetes and osteoporosis: part i, epidemiology and pathophysiology. Endocrinol Metab Clin North Am. 2021;50(2):275–285. doi:10.1016/j.ecl.2021.03.005
  • Napoli N, Chandran M, Pierroz DD, et al. Mechanisms of diabetes mellitus-induced bone fragility. Nat Rev Endocrinol. 2017;13(4):208–219. doi:10.1038/nrendo.2016.153
  • Kurra S, Fink DA, Siris ES. Osteoporosis-associated fracture and diabetes. Endocrinol Metab Clin North Am. 2014;43(1):233–243. doi:10.1016/j.ecl.2013.09.004
  • Mohsin S, Baniyas MM, Aldarmaki RS, et al. An update on therapies for the treatment of diabetes-induced osteoporosis. Expert Opin Biol Ther. 2019;19(9):937–948. doi:10.1080/14712598.2019.1618266
  • Reid IR, Bristow SM, Bolland MJ. Calcium supplements: benefits and risks. J Intern Med. 2015;278(4):354–368. doi:10.1111/joim.12394
  • Corsetti M, Brown S, Chiarioni G, et al. Chronic constipation in adults: contemporary perspectives and clinical challenges. 2: conservative, behavioural, medical and surgical treatment. Neurogastroenterol Motil. 2021;33(7):e14070. doi:10.1111/nmo.14070
  • Van Oudenhove L, Vandenberghe J, Demyttenaere K, et al. Psychosocial factors, psychiatric illness and functional gastrointestinal disorders: a historical perspective. Digestion. 2010;82(4):201–210. doi:10.1159/000269822
  • Gonzalez JS, Tanenbaum ML, Commissariat PV. Psychosocial factors in medication adherence and diabetes self-management: implications for research and practice. Am Psychol. 2016;71(7):539–551. doi:10.1037/a0040388
  • Bouchoucha M, Fysekidis M, Deutsch D, et al. Biopsychosocial model and perceived constipation severity according to the constipation phenotype. Dig Dis Sci. 2021;66(10):3588–3596. doi:10.1007/s10620-020-06654-z
  • Owens-Gary MD, Zhang X, Jawanda S, et al. The importance of addressing depression and diabetes distress in adults with type 2 diabetes. J Gen Intern Med. 2019;34(2):320–324. doi:10.1007/s11606-018-4705-2